Trivascular Technologies Inc. shares jumped in the extended session Monday after Endologix Inc. agreed to acquire the medical device company for $211 million in stock and cash. Trivascular shares surged 55% to $7.80, but still fell short of the transaction value of $9.10 a share. Endologix shares were flat at $13.73. Trivascular also said it expects third-quarter revenue of $9.5 million, while analysts surveyed by FactSet expect $9.3 million.
Copyright © 2015 MarketWatch, Inc.
Continue Reading Below